Physician profile
Hannah E Howard
NPI 1902293020
$2,940.43
in general payments reported to CMS, 2019-2025
17 companies · $510 in 2025
The $510 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $418 · 2020: $148 · 2021: $99.99 · 2022: $228 · 2023: $673 · 2024: $864 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,957 · Education: $89.09.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,957.49 |
| Education | $89.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.65 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $657.70 | 2022-2025 | Sotyktu |
| Janssen Biotech, INC. | $323.68 | 2021-2025 | Tremfya |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $238.53 | 2019-2024 | Siliq |
| Amgen INC. | $171.96 | 2023-2025 | Otezla, Repatha, Otezla |
| Ucb, INC. | $111.91 | 2024 | Bimzelx |
| Allergan, INC. | $97.33 | 2019 | |
| Novartis Pharmaceuticals Corporation | $94.31 | 2019-2025 | |
| Dermavant Sciences, INC. | $94.15 | 2022-2024 | Vtama |
| Pfizer INC. | $90.13 | 2022-2024 | |
| Lilly USA, LLC | $86.37 | 2019-2023 | Taltz, Olumiant |
| Regeneron Healthcare Solutions, INC. | $43.19 | 2020 | |
| Organon LLC | $31.98 | 2025 | Nexplanon, Vtama |
| Vyne Pharmaceuticals INC. | $28.88 | 2020 | |
| Galderma Laboratories, L.P. | $20.28 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $20.12 | 2025 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $14.26 | 2023 | Verquvo, Belsomra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hannah Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.